US Stock MarketDetailed Quotes

CLDI Calidi Biotherapeutics

Watchlist

1.590
-0.170-9.66%

Close Jul 22 16:00 ET

10.21MMarket Cap-193P/E (TTM)

Calidi Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

Total revenue

-89.98%45K

449K

405K

Operating revenue

--0

-89.98%45K

--0

--449K

--405K

Cost of revenue

-85.11%14K

94K

50K

Gross profit

-91.27%31K

355K

Operating expense

42.96%6.75M

12.73%26.11M

96.42%9.21M

-6.56%6.53M

4.72M

113.70%23.16M

41.20%4.69M

6.99M

60.00%10.84M

3.32M

Selling and administrative expenses

43.59%4.01M

0.52%15.98M

141.73%5.86M

-21.25%3.97M

--2.79M

158.02%15.9M

24.68%2.43M

--5.04M

71.62%6.16M

--1.95M

-General and administrative expense

43.59%4.01M

0.52%15.98M

141.73%5.86M

-21.25%3.97M

--2.79M

158.02%15.9M

24.68%2.43M

--5.04M

71.62%6.16M

--1.95M

Research and development costs

4.61%2.74M

79.25%13.01M

74.90%3.96M

67.15%3.25M

--2.62M

55.26%7.26M

64.58%2.26M

--1.95M

46.89%4.67M

--1.38M

Other operating expenses

----

---2.89M

---612K

---693K

---691K

----

Operating profit

-42.96%-6.75M

-12.88%-26.11M

-96.42%-9.21M

6.56%-6.53M

-4.72M

-120.64%-23.13M

-58.11%-4.69M

-6.99M

-54.76%-10.48M

-2.97M

Net non-operating interest income expense

-16.59%-253K

-2,272.78%-3.75M

-126.53%-222K

-1,017.24%-324K

-217K

74.27%-158K

-58.06%-98K

-29K

-276.69%-614K

-62K

Non-operating interest expense

16.59%253K

576.58%1.07M

126.53%222K

1,017.24%324K

--217K

-74.27%158K

58.06%98K

--29K

276.69%614K

--62K

Total other finance cost

----

--2.68M

--0

----

Other net income (expense)

85.77%-216K

130.80%656K

140.30%1.2M

191.33%4.84M

-1.52M

-1,324.14%-2.13M

-547.71%-2.97M

1.66M

117.45%174K

-459K

Gain on sale of security

86.85%-199K

155.44%1.18M

141.22%1.22M

220.94%5.32M

---1.51M

-1,032.02%-2.13M

-257.92%-2.96M

--1.66M

121.55%228K

---827K

Special income (charges)

----

---471K

--0

---471K

----

--0

-210.53%-63K

--362K

-Less:Other special charges

----

--471K

--0

--471K

----

210.53%63K

---362K

Other non- operating income (expenses)

-240.00%-17K

-920.00%-51K

-69.23%-22K

-300.00%-8K

---5K

-155.56%-5K

-316.67%-13K

--4K

125.00%9K

--6K

Income before tax

-11.81%-7.22M

-14.89%-29.2M

-6.10%-8.23M

62.40%-2.01M

-6.46M

-132.70%-25.42M

-122.58%-7.76M

-5.35M

-37.68%-10.92M

-3.49M

Income tax

0.00%4K

45.45%16K

0.00%-3K

1,000.00%11K

0.00%11K

-200.00%-3K

175.00%11K

Net income

-11.81%-7.23M

-14.90%-29.22M

-6.10%-8.23M

62.20%-2.02M

-6.46M

-132.57%-25.43M

-122.30%-7.76M

-5.36M

-37.75%-10.93M

-3.49M

Net income continuous Operations

-11.81%-7.23M

-14.90%-29.22M

-6.10%-8.23M

62.20%-2.02M

---6.46M

-132.57%-25.43M

-122.30%-7.76M

---5.36M

-37.75%-10.93M

---3.49M

Minority interest income

Net income attributable to the parent company

-11.81%-7.23M

-14.90%-29.22M

-6.10%-8.23M

62.20%-2.02M

-6.46M

-132.57%-25.43M

-122.30%-7.76M

-5.36M

-37.75%-10.93M

-3.49M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-11.81%-7.23M

-14.90%-29.22M

-6.10%-8.23M

62.20%-2.02M

-6.46M

-132.57%-25.43M

-122.30%-7.76M

-5.36M

-37.75%-10.93M

-3.49M

Basic earnings per share

-11.13%-2

-144.30%-17.3

-7.25%-2.3166

6.13%-1.4

-1.7997

-132.57%-7.0814

-122.30%-2.1601

-1.4914

-37.75%-3.0449

-0.9717

Diluted earnings per share

-11.13%-2

-144.30%-17.3

-7.25%-2.3166

6.13%-1.4

-1.7997

-132.57%-7.0814

-122.30%-2.1601

-1.4914

-37.75%-3.0449

-0.9717

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021
Total revenue	0	0	0	0	0	-89.98%45K	0	0	449K	405K
Operating revenue	--0	--0	--0	--0	--0	-89.98%45K	--0	--0	--449K	--405K
Cost of revenue		0	0	0		-85.11%14K	0	0	94K	50K
Gross profit		0	0	0		-91.27%31K	0	0	355K	355K
Operating expense	42.96%6.75M	12.73%26.11M	96.42%9.21M	-6.56%6.53M	4.72M	113.70%23.16M	41.20%4.69M	6.99M	60.00%10.84M	3.32M
Selling and administrative expenses	43.59%4.01M	0.52%15.98M	141.73%5.86M	-21.25%3.97M	--2.79M	158.02%15.9M	24.68%2.43M	--5.04M	71.62%6.16M	--1.95M
-General and administrative expense	43.59%4.01M	0.52%15.98M	141.73%5.86M	-21.25%3.97M	--2.79M	158.02%15.9M	24.68%2.43M	--5.04M	71.62%6.16M	--1.95M
Research and development costs	4.61%2.74M	79.25%13.01M	74.90%3.96M	67.15%3.25M	--2.62M	55.26%7.26M	64.58%2.26M	--1.95M	46.89%4.67M	--1.38M
Other operating expenses	----	---2.89M	---612K	---693K	---691K	----	----	----	----	----
Operating profit	-42.96%-6.75M	-12.88%-26.11M	-96.42%-9.21M	6.56%-6.53M	-4.72M	-120.64%-23.13M	-58.11%-4.69M	-6.99M	-54.76%-10.48M	-2.97M
Net non-operating interest income expense	-16.59%-253K	-2,272.78%-3.75M	-126.53%-222K	-1,017.24%-324K	-217K	74.27%-158K	-58.06%-98K	-29K	-276.69%-614K	-62K
Non-operating interest expense	16.59%253K	576.58%1.07M	126.53%222K	1,017.24%324K	--217K	-74.27%158K	58.06%98K	--29K	276.69%614K	--62K
Total other finance cost	----	--2.68M	--0	----	----	----	----	----	----	----
Other net income (expense)	85.77%-216K	130.80%656K	140.30%1.2M	191.33%4.84M	-1.52M	-1,324.14%-2.13M	-547.71%-2.97M	1.66M	117.45%174K	-459K
Gain on sale of security	86.85%-199K	155.44%1.18M	141.22%1.22M	220.94%5.32M	---1.51M	-1,032.02%-2.13M	-257.92%-2.96M	--1.66M	121.55%228K	---827K
Special income (charges)	----	---471K	--0	---471K	----	--0	--0	--0	-210.53%-63K	--362K
-Less:Other special charges	----	--471K	--0	--471K	----	----	----	----	210.53%63K	---362K
Other non- operating income (expenses)	-240.00%-17K	-920.00%-51K	-69.23%-22K	-300.00%-8K	---5K	-155.56%-5K	-316.67%-13K	--4K	125.00%9K	--6K
Income before tax	-11.81%-7.22M	-14.89%-29.2M	-6.10%-8.23M	62.40%-2.01M	-6.46M	-132.70%-25.42M	-122.58%-7.76M	-5.35M	-37.68%-10.92M	-3.49M
Income tax	0.00%4K	45.45%16K	0.00%-3K	1,000.00%11K	4K	0.00%11K	-200.00%-3K	1K	175.00%11K	3K
Net income	-11.81%-7.23M	-14.90%-29.22M	-6.10%-8.23M	62.20%-2.02M	-6.46M	-132.57%-25.43M	-122.30%-7.76M	-5.36M	-37.75%-10.93M	-3.49M
Net income continuous Operations	-11.81%-7.23M	-14.90%-29.22M	-6.10%-8.23M	62.20%-2.02M	---6.46M	-132.57%-25.43M	-122.30%-7.76M	---5.36M	-37.75%-10.93M	---3.49M
Minority interest income
Net income attributable to the parent company	-11.81%-7.23M	-14.90%-29.22M	-6.10%-8.23M	62.20%-2.02M	-6.46M	-132.57%-25.43M	-122.30%-7.76M	-5.36M	-37.75%-10.93M	-3.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-11.81%-7.23M	-14.90%-29.22M	-6.10%-8.23M	62.20%-2.02M	-6.46M	-132.57%-25.43M	-122.30%-7.76M	-5.36M	-37.75%-10.93M	-3.49M
Basic earnings per share	-11.13%-2	-144.30%-17.3	-7.25%-2.3166	6.13%-1.4	-1.7997	-132.57%-7.0814	-122.30%-2.1601	-1.4914	-37.75%-3.0449	-0.9717
Diluted earnings per share	-11.13%-2	-144.30%-17.3	-7.25%-2.3166	6.13%-1.4	-1.7997	-132.57%-7.0814	-122.30%-2.1601	-1.4914	-37.75%-3.0449	-0.9717
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall